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Aim. To assess the inhibitory activity of ellagitannin complex of the purified extract from the 
fruits of white alder and black alder in non-eukaryotic polymerase systems and to analyze the 
effects of these substances on the reverse transcriptase of murine leukemia virus and HIV 
reproduction in vitro. Methods. Chronically infected MT4/BIII culture of human leukemic 
cells was used as the HIV source. Anti-HIV activity of the ellagitannin-containing extract was 
estimated by the reduction of HIV infectious titer in the MT-4 cells. The inhibitory effects of 
the extract on retroviral reverse transcriptase, T7 RNA-polymerase and Taq polymerase were 
also studied in cell-free systems. Results. The ellagitannin extract inhibited activities of the 
reverse transcriptase of murine leukemia retrovirus, T7 RNA-polymerase, and Taq polymerase. 
It also  reduced the HIV infectious titer in MT-4 cells with IC50 of 1.5 μg/ml and selectivity 
index of 87. Conclusions. The ellagitannin complex possesses a significant anti-HIV activity. 
Its  in vitro antiviral effect is achieved with a relatively low toxicity.
K e y w o r d s: ellagitannins, HIV, anti-HIV activity, reverse transcriptase, T7 RNA-polymerase, 
Taq polymerase.
Introduction
Natural products of plant origin are widely 
used as the remedies in the traditional herbal 
medicine and considered as the sources for 
various pharmaceutical applications. Different 
classes of phenolic compounds are extensive-
ly studied as the potential antiviral substan-
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ces [1]. Gallotannins and ellagitannins as the 
major groups of hydrolysable tannins represent 
an important class of polyphenolic compounds. 
They are widely distributed in many species 
of plants and identified as the active constitu-
ents of the traditional Chinese herbal prepara-
tions used for many centuries as anti-inflam-
matory, hemostatic, and astringent remedies. 
Ellagitannins are the esters of hexahydroxy-
diphenic acid and monosaccharide tending to 
form high molecular weight dimers and oligo-
mers. The chemical structure and the biologi-
cal activities of isolated individual ellagitannin 
species have been extensively studied [2]. The 
potent antioxidant activity of many ellagitan-
nins contributing to their antibacterial proper-
ties has been demonstrated [3]. 
More recently, several more specific activi-
ties of ellagitannins have been discovered. The 
remarkable chemical stability of most ellagitan-
nins proved to be advantageous for evaluating 
their biological and pharmacological activities. 
A number of the reports disclosed antiprolif-
erative, proapoptotic, and antiangiogenic ac-
tivities of these substances [4]. Several studies 
have been initiated to assess possible antiviral 
activities of ellagitannins. These substances 
turned out to inhibit reproduction of the envel-
oped viruses of various taxonomic groups due 
to binding different proteins and altering their 
structure. The monomeric hydrolyzable tan-
nins, oligomeric ellagitannins and condensed 
tannins possessing galloyl or hexahydroxy-
diphenoyl groups have been shown to inhibit 
herpes simplex virus infection [5, 6]. Several 
studies demonstrated the activity of hydrolys-
able tannins against hepatitis C virus [7].
The natural products as antiviral and in par-
ticular anti-HIV agents have been in the focus 
of numerous studies [8]. A lot of research on the 
herbal compounds as anti-HIV substances have 
been performed. The substances from various 
classes of polyphenolics seem to be promising 
for supplementing anti-HIV therapy [9]. 
Nevertheless, the data on anti-HIV activities of 
hydrolysable tannins, in particular ellagitannins, 
are scarce. It has been shown that several ella-
gitannins inhibit HIV-induced cytopathic effects 
and HIV-specific antigen expression [10, 11]. 
However, the mechanisms of antiviral activities 
of ellagitannins have not yet been elucidated. 
A number of virus-specific enzymes related 
to DNA and RNA synthesis, i.e., transcription, 
reverse transcription, replication, DNA relax-
ation, etc. are proved as the effective targets 
for the therapeutic agents. The vast majority of 
the antiviral substances have been designed as 
the inhibitors of virus-specific polymerases 
since viral enzymes differ from polymerases 
involved in maintaining the replication in non-
infected cells. In fact, ellagitannins and natural 
products in general seem to target various 
stages in the replicative cycle of viruses that 
are under control of specific enzymes of virions 
or enzymes synthesized on the templates of 
viral nucleic acids. In particular, in antiretrovi-
ral therapy the widely used drugs represent the 
inhibitors of HIV reverse transcriptase and HIV 
protease [12]. Kakiuchi et al. demonstrated the 
inhibitory activity of tannins on reverse tran-
scriptase from RNA tumor virus [13]. These 
data were confirmed by inhibition of HIV re-
verse transcriptase with the gallotannin-con-
taining fraction and the isolated ellagitannins 
geraniin and corilagin [14]. The fact that these 
substances inhibit reverse transcriptases of the 
inhibitor-resistant HIV variants is of particular 
interest taking into account that high HIV vari-
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ability and the development of resistant strains 
is a serious problem for the chemotherapy of 
HIV infection. Several ellagitannins demon-
strated anti-protease activities in both HIV and 
hepatitis C virus infection [7, 15]. 
The assays of putative HIV inhibitors in 
the systems with various nucleic acid 
polymerases such as viral DNA polymerases 
and RNA-dependent RNA polymerases may be 
crucial as the first stage of antiviral drug 
screening [16]. The previous studies suggested 
that the combination of several non-eukaryotic 
polymerase systems may be useful as the 
primary screening tool for antiviral substances 
of different classes of natural and synthetic 
compounds [17]. Earlier, this system was 
successfully used in the screening of several 
herbal flavonoids as the putative antiviral agents 
[18]. Later on, we confirmed their anti-HIV 
activity in specific assays [19]. Bearing in mind 
the recent data on the anti-HIV effects of several 
ellagitannins [10, 11, 13], we attempted to use 
the similar methodological approach in assessing 
the presumed anti-HIV activities of ellagitannin 
complex of the purified extract from the fruits 
of white alder and black alder.
The aim of the present research was to as-
sess the inhibitory activity of ellagitannins in 
non-eukaryotic polymerase systems for screen-
ing and further analyzing the effects of these 
substances on the activities of the reverse tran-
scriptase of murine leukemia virus and HIV 
reproduction in vitro. 
Materials and Methods
Viruses
The stock of the laboratory adapted ВІІІ strain 
of HIV-1 was obtained from the Depository of 
Viruses of D.I. Ivanovskii Institute of Virology 
(Moscow, Russia). The virus was maintained in 
chronically infected virus-producing МТ4/ВІІІ 
culture of lymphoblastoid cells. Earlier, the 
indirect immunofluorescence with anti-p24 
monoclonal antibody confirmed that practically 
all the cells in culture were infected. The virus-
containing culture fluid was stored at –70 °C. 
Virus of murine leukemia (MuLV) was pro-
duced by NML cells kindly provided by 
Dr. Yu. Kudriavets (R.E. Kavetsky Institute of 
Experimental Pathology, Oncology and 
Radiobiology, NAS of Ukraine). The concen-
trated culture medium of NML cells was used 
as a source of the reverse transcriptase. 
In vitro virological assays were performed 
in the Laboratory of Experimental Chemo the-
rapy of Viral Infections, L.V. Gromashevsky 
Institute of Epidemiology and Infectious 
Diseases, NAMS of Ukraine that was certified 
by SE Ukrmetrteststandard as conforming to 
the requirements of Good Laboratory Practice 
for research of antiviral activities of chemical 
and herbal substances in animals and in cell 
cultures (PT No. 426/14 of December 8, 2014). 
Cell cultures
MT-4 cell line originated from human T-cell 
acute leukemia was obtained from the Cell 
Depository of R.E. Kavetsky Institute of 
Experimental Pathology, Oncology and 
Radiobiology of the NAS of Ukraine. The cells 
were cultured in suspension by conventional 
techniques in RPMI 1640 medium with 10 % 
of fetal calf serum (Sigma, USA) supplement-
ed with gentamicin (40 µg/mL). The culture 
was passaged once in 3–4 days by dilution 
with fresh medium at an initial cell density of 
2.5 × 105 cells/ml. 
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The primary culture of human embryonic 
cells was obtained by trypsinization of human 
embryonic tissue (12–14 weeks). The use of 
human embryonic tissue in the experiments 
was strictly adhered to the Law of Ukraine 
“About organ transplantation and other ana-
tomic materials to the person” No. 1007-XIV 
(Section 19) in version of October 26, 2014 in 
conformance with the Convention for the 
Protection of Human Rights and Dignity of the 
Human Being with regard to the Application 
of Biology and Medicine: Convention on 
Human Rights and Biomedicine (ETS No.164). 
Ellagitannin-containing extract 
The extract from the fruits of white alder and 
black alder (Alnus qlutinosa L.Gaern and 
Alnus incana L. Moench) was obtained and 
partially purified at the Research-and Scientific 
Department of “Borshchahivskiy” CPP PJSC 
(Kyiv, Ukraine). The ellagitannins in dry ex-
tract (not less than 58 %) were represented by 
the monomeric, dimeric and oligomeric com-
pounds containing hexahydroxydiphenic acid 
and valoneic acid dilacton with monomeric 
ellagitannins amounting to 15–20 % of ellagi-
tannin content. The sterile dry extract was 
diluted in RPMI-1640 medium.
Cytotoxicity assay
MTT test was used to assess the cytotoxicity 
of the extract. MT-4 cells were seeded in a 
96-well plate (5 × 104 per well in a volume of 
200 µl) and various concentrations of the ex-
tract were added in triplicate. The cells were 
incubated for 5 days at 37 °C in a 5 % CO2-
humidified incubator. Then MTT (5 mg/mL in 
PBS) was added to each well. After incubating 
for 4 hours, the plates were centrifuged at 
1,500 rpm, the supernatant was removed and 
the dimethyl sulfoxide was added. The plate 
was incubated for 10 min at 37 °C and read on 
a Bio-Tek Elx 800 ELISA reader at 570 nm. 
50 % cytotoxic concentration (CC50) was then 
calculated.
Assay for HIV infectious titer and 
p24 detection 
The fresh MT4 cells in 96-well plates were 
infected in three replicates with 10-fold dilu-
tions of HIV-1 produced by МТ4/ВІІІ cells. 
The plates were incubated for 5 days at 37 °C 
in 5 % CO2-humidified incubator. The content 
of p24 HIV was assayed in each well for cal-
culating 50 % end point dilution of virus. p24 
expression in culture medium was detected by 
EIA with DIA-HIV-Ag/Ab test-system (DIA, 
Ukraine). The neutralization reaction was ap-
plied to confirm the presence of р24 HIV in 
the samples. The diagnostic set Genetic 
SystemsTM HIV-1 Confirmatory Assay used 
for this aim comprised the human serum con-
taining antibodies against р24 as HIV-1 
Antigen Confirmatory Reagent. The neutraliza-
tion index was calculated according to the 
manufacturer’s instructions.
Antiviral activity of ellagitannin-
containing extract 
Anti-HIV activity of the extract was estimated 
by the reduction of HIV infectious titer in 
MT-4 cells. The cells in 96-well plates were 
treated with serial dilutions of the reconsti-
tuted extract in triplicate and infected with HIV 
(100 ID50 per well). The plates were incubated 
for 5 days at 37 °C in 5 % CO2-humidified 
incubator. The supernatants were harvested 
from each well and titrated for infectious virus 
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in fresh MT-4 cells. The inhibitory effects on 
HIV-1 replication in acute infection were as-
sessed by quantification of p24 by ELISA as 
previously described and expressed as IC50 
(inhibitory concentration decreasing HIV in-
fectious titer in half). To assess the specific 
antiviral activity, CC50/IC50 ratio was calcu-
lated and presented as the selectivity index. 
Reverse transcriptase assay
Supernatants of MuLV-produced NML cells 
were harvested and assayed for RNA-dependent 
DNA polymerase activity in 100-fold concen-
trates of virus obtained by centrifugation at 
100,000 g for 1 h. The reaction mixture 
(100 µl) contained 50 mM Tris-HCI, pH 7.8; 
60 mM potassium chloride; 2 mM dithiotreitol; 
0.25 mM MnCl2; 0.1 % (v/v) Triton X-100; 
0.02 AU/ml poly rA-oligo dT12 and 20 µM 
3H-TTP, specific activity 2.37 TBq/mmol 
(Amersham, Great Britain). The samples were 
incubated at 37 °C for 60 min. Trichloroacetic 
acid-insoluble radioactivity was measured in 
Intertechnique SL30 counter (France). 
In vitro transcription assay
The reaction mixture (20 μl) of transcription 
assay contained the linearized DNA template 
pTZ19R* (0.5 mg of pTZ19R plasmid with a 
341 bp insert cloned in the Ecl136II site), ri-
bonucleoside triphosphates (2 mM of each), 
ribonuclease inhibitor RiboLockTM (10 U), 
T7 RNA polymerase (12 U) (Fermentas, 
Lithuania), Tris-HCl (40 mM, pH 7.9), MgCl2 
(6 mM), spermidine (2 mM), NaCl (10 mM) 
and dithiothreitol (10 mM). The sterile dry 
ellagitannin-containing extract diluted in 
DMSO (1 mg/ml) was added to the reaction 
mixture and the mixture was incubated for 
45 min at 37 ºC. The final concentration of 
DMSO in reaction mixture was below 1 %. 
Then the reaction was stopped by cooling up 
to –20 ºC, and the products were separated by 
gel electrophoresis in 1 % agarose in TBE 
buffer supplemented with ethidium bromide 
(0.5 mg/ml) followed by visualization under a 
standard UV-transilluminator. For calculations, 
the intensity of electrophoretic bands was mea-
sured by densitometry using Scion Image soft-
ware for Windows and IC50 values for inhibi-
tion of RNAP T7 activity were estimated. 
PCR-based replication assay 
For a standard PCR, the reagent kit provided 
by (Thermo Fisher Scientific, Lithuania) was 
used. The linearized pTZ19R* was used as a 
template (5 ng in 20 μl of incubation mixture) 
with the designed and synthesized specific 
forward and the reverse primers (1.1 pmol of 
each in 20 μl of reaction mixture). PCR prod-
ucts were separated by electrophoresis in 1 % 
agarose and visualized as above.
Mitotic index and cytogenetic analysis
The effects of ellagitannin-containing extract 
on mitotic activity and chromosomes were 
studied in primary cultures of human embry-
onic tissue. The cells were cultured onto the 
cover slips, fixed in ethanolic copper nitrate — 
formalin and stained with hematoxylin — eo-
sin. The mitotic index was assessed in 3000 
cells and expressed in parts per thousand (‰). 
In the same cell specimens, the percent of 
pathologic mitoses was estimated. The cyto-
genetic analysis was performed in metaphase 
plates of cells exposed to 0.75 mg/mL of col-
chicine and processed by standard technique: 
treatment with 1 % sodium citrate, fixation in 
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methanol — glacial acetic acid, staining with 
azur-eosin.
Results and Discussion
As the first step in the analysis of ellagitannin 
extract as the potential antiviral substance, its 
effects were studied in two screening systems 
containing the enzymes, which are extraneous 
to eukaryotic cells, namely DNA-dependent 
RNA polymerase of T7 bacteriophage and Taq 
DNA polymerase. When assayed in the tran-
scriptional complex of T7 phage RNA poly-
merase, ellagitannin extract demonstrated an 
effective inhibition of RNA synthesis with IC50 
value of 0.4 μg/ml (Fig. 1). The ellagitannin 
extract was even more active (IC50 of 0.15 μg/
ml) in the system of DNA synthesis in the set-
ting of PCR (Fig. 2). Therefore, both RNA 
synthesis catalyzed by T7 RNA polymerase 
and synthesis of DNA fragments by Taq poly-
merase were sensitive to the inhibition by el-
lagitannin extract in concentration-dependent 
mode. The inhibitory concentrations in cell-
free system were of the same order of magni-
tude as those found for several flavonoid sub-
stances assayed in our previous work [18] that 
provided good reason for assessing ellagitan-
nins under study as antiviral substances in the 
specific system of HIV-producing cells.
The routine procedures for the assessment 
of specific antiviral activity require evaluation 
of the toxicity indices (CC50) in the cells being 
assayed and the concentrations effective for 
antiviral activity (IC50). The cytotoxicity of 
ellagitannin extract was assessed in MTT assay 
in MT-4 cells. The dilutions of the extract were 
added for 1 h to the wells of microplates with 
suspension of cells (each dilution was assayed 
in three replicates). Then the medium was 
removed and fresh medium was added for 
72 h. The results of the cytotoxicity assay 
(Fig. 3) show that CC50 of ellagitannin extract 
for MT-4 cells is 87 µg/ml. 
Then the anti-HIV activity of ellagitannin 
extract was assayed in the model of productive 
infection of HIV in MT-4 cells. For this pur-
pose, МТ4/ВІІІ cells continuously producing 
HIV-1 were used. For characterizing the pa-
rameters of HIV productive infection in МТ4/
ВІІІ cells we first confirmed the identity of 
HIV produced by МТ4/ВІІІ cells with HIV-1 
by neutralization with human anti-p24 HIV-1 
antiserum. The neutralization index for HIV 
in MT-4 cells was calculated as 98.4 %. To 
prove the infectivity of the virus produced by 
МТ4/ВІІІ cells for MT-4 cells and to assess 
Fig. 1. Inhibition of RNA synthesis in vitro in T7 RNA 
polymerase system. The absence of the visualized band 
corresponding to reaction product in agarose gel means 
the complete inhibition. 1 — control; 2-6 — ellagitannin: 
2 — 12.8 µg/ml; 3 — 3.2 µg/ml; 4 — 0.8 µg/ml, 5 — 
0.2 µg/ml; 6 — 0.05 µg/ml.
Fig. 2. Inhibition of DNA synthesis in vitro in Taq poly-
merase system. The absence of the visualized band cor-
responding to reaction product in agarose gel means the 
complete inhibition. 1 — control; 2–7 — ellagitannin: 
2 — 12.8 µg/ml; 3 — 3.2 µg/ml; 4 — 0.4 µg/ml; 5 — 
0.1 µg/ml; 6 — 0.05 µg/ml; 7 — 0.012 µg/ml
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HIV infectious titer in MT-4 cells we have 
infected fresh MT-4 cell suspensions with 
10-fold serial dilutions of HIV produced in 
МТ4/ВІІІ cells (each dilution of virus was as-
sayed in triplicate). 
HIV infectious titer in MT-4 cells was esti-
mated by detection of infectivity for MT-4 
cells in 10-fold serial dilutions of HIV pro-
duced in МТ4/ВІІІ cells (each dilution of virus 
was assayed in triplicate). The 50 % end-point 
dilution was measured by p24 assay. The infec-
tious HIV titer in MT4 cells calculated by 
Reed-Muench equaled 4.6 lgID50 (Fig. 4). 
The Anti-HIV activity of the extract was 
estimated by the reduction of the HIV infectious 
titer in MT-4 cells. The serial dilutions of the 
extract within the range of 0.5–40 µg/ml were 
prepared and applied to each well with MT-4 
cells simultaneously with 100 ІD50 of HIV (each 
dilution of the extract in triplicate). After 5-day 
incubation, HIV titer in each well was assayed 
by titration of the culture medium in fresh MT4 
cells as indicated above. As shown in Fig. 5, 
Fig. 3. Cytotoxicity of ellagitannin 
extract in MT-4 cells. Cells were in-
cubated with serial dilutions of the 
extract for 5 days. Percent of viable 
cells was assayed in MTT test. CC50 
was calculated by linear regression. 
CC50 value is marked with arrow. 
Fig. 4. Titration of HIV in MT-4 cells. The cells were 
infected with 10-fold dilutions of HIV-1 in three repli-
cates and the plates were incubated for 5 days at 37 °C. 
The supernatants from the cells infected in each dilution 
were then harvested and titrated for infectious virus in 
fresh MT-4 cells. p24 in culture medium was detected by 
EIA using DIA-HIV-Ag/Ab test-system. 
the ellagitannin extract exhibited the anti-HIV 
activity inhibiting the infectious titer of virus in 
MT-4 cells. IC50 calculated by linear regression 
was 1.5 µg/ml and IC90 — 5.0 µg/ml. Therefore, 
the ellagitannin extract effectively inhibits HIV 
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reproduction causing the reduction of HIV in-
fectivity by 1 log ІD50 in the concentration of 
5 µg/ml producing quite favorable CC50 to IC50 
and CC50 to IC90 ratios. 
Tannins, and in particular ellagitannins are 
multi-target substances and it is difficult to 
delineate the principal effects contributing to 
their antiviral activity. Nevertheless, most syn-
thetic and natural HIV inhibitors are known to 
mediate their activity via inhibition of viral 
enzymes. Therefore, we have attempted to mea-
sure the putative inhibitory activities of ellagi-
tannin extract in cell-free system. RT is one of 
the key targets of many synthetic HIV inhibi-
tors designed as retroviral drugs [20]. We ana-
lyzed the effect of the extract on MuLV reverse 
transcriptase that shares many similarities in 
Fig. 5. IC50 and IC90 for inhibition of HIV infectivity in MT-4 
cells by ellagitannin extract. The serial dilutions of the extract 
were applied to each well with MT-4 cells simultaneously with 
100 ІD50 of HIV (each dilution of the extract in triplicate). The 
cells with virus and dilutions of the extract as well as controls 
were incubated for 5 days at 37 °C. Upon the incubation, HIV 
titer in each well was assayed by titration of the culture medi-
um in fresh MT4 cells. The decrease in HIV infectious titer 
was assessed. IC50 (decline of virus titer in half) and IC90 (ten-
fold decline of virus titer) were calculated by linear regression. 
IC50 and IC90 values are marked with arrows.
Fig. 6. Effect of ellagitannin extract on reverse transcrip-
tase activity of murine leukemia virus. The extract redis-
solved in polyethylene oxide 400 was added to the incu-
bation system for assaying the activity of reverse tran-
scriptase with poly rA – oligo dT used as exogenous 
template. The reaction was terminated in 1 hour and tri-
chloroacetic acid-insoluble radioactivity in the samples 
with or without extract was measured as the amount of 
3H-TTP incorporation. 
its enzymatic and molecular characteristics 
with HIV reverse transcriptase although some 
subtle differences do exist [21]. Fig. 6 demon-
strates that an addition of the extract to the 
complete incubation mixture in concentrations 
within 20-200 µg/mL resulted in the significant 
inhibition of 3H-TTP incorporation into poly 
rA — oligo dT used as exogenous template for 
MuLV reverse transcriptase. At 20 µg/mL, the 
inhibiting effect amounted to 60 %. 
 Further evidence for the safety of the com-
position under study was provided by analy zing 
mitotic parameters and chromosomal aberra-
tions in the cells of primary cultures of human 
embryonic tissue cultured in the presence of 
ellagitannins in concentration of 20 μg/ml. The 
results are presented in Table.
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Therefore, ellagitannins in concentrations 
well above IC50 for HIV reproduction did not 
affect the mitotic parameters. The count of 
chromosomal aberrations was not significant-
ly higher than in control cultures. Moreover, 
only gaps were detected as the dominant form 
of chromosomal aberrations. These parameters 
of safety are in line with the data on cytotoxic-
ity of the assayed extract.
The screening system used in our study 
seemed to be helpful in selecting potential 
antivirals without the need of specific HIV 
assays at the first step. Actually, the prelimi-
nary screening of the ellagitannin complex of 
the purified extract from the fruits of white 
alder and black alder turned out to be promis-
ing for the subsequent specific anti-HIV assays 
that finally confirmed the significant anti-HIV 
activity in the productive system of HIV-
infected MT-4 cells. 
The relative effectiveness and specificity of 
any investigational drug in inhibiting viral 
replication as compared to inducing cell death 
is defined as the therapeutic or selectivity in-
dex (SI). With IC50 of 1.5 μg/ml and CC50 of 
87 µg/ml, SI of ellagitannins under study in 
our system of HIV-producing MT-4 cells 
amounts to 57. According to the currently ac-
cepted methodical guides for the development 
of the antivirals, the substances with SI above 
4 are considered as positive whereas the sub-
stances with SI above 8 may be considered as 
the promising candidate substances and recom-
mended for the next step of in vivo experimen-
tal studies [22, 23] 
Our results are in agreement with those 
presented elsewhere for the substances of this 
class as antiviral agents. In particular, Cheng 
et al. demonstrated anti-HSV-2 activity of 
casuarinin in vitro with IC50 of 1.5 μg/ml [24]. 
Recently, Bedoya et al. demonstrated anti-HIV 
activity of ellagitannins with IC50 of 2.3 μg/
ml and SI of 20 [25]. 
Conclusions
The ellagitannin complex of the purified extract 
from the fruits of white alder and black alder 
possesses significant anti-HIV activity inhibit-
ing effectively the HIV reproduction in vitro in 
human MT-4 cells with IC50 of 1.5 μg/ml and 
IC90 of 5.0 µg/ml. In the experimental setting, 
the ellagitannin extract inhibits the activities of 
reverse transcriptase of murine leukemia virus, 
T7 RNA-polymerase, and Taq polymerase. The 
advantageous antiviral effects are achieved 
with low toxicity providing for acceptable val-
ues of a selectivity index. The further analysis 
of possible interactions between the various 
components of this herbal extract would be 
beneficial for designing the novel drugs to re-
duce or block the HIV reproduction. 
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Анти-ВІЛ активність елаготанінів із суплідь 
вільхи 
Т. Ю. Трохимчук, А. С. Шаламай, М. П. Завелевич, 
Л. Г. Пальчиковська, О. В. Васильченко, 
С. Л. Рибалко, Д. Б. Старосила, С. Т. Дядюн 
Мета. Оцінити інгібувальну активність комплексу ела-
готанінів в очищеному екстракті плодів вільхи сірої і 
вільхи клейкої у відношенні полімераз, що не є поліме-
разами еукаріот, з метою скринінгу та проаналізувати 
вплив досліджуваних речовин на зворотну транскрип-
тазу вірусу мишачої лейкемії та на репродукцію ВІЛ in 
vitro. Методи. Джерелом ВІЛ була хронічно інфікована 
культура клітин лейкемії людини МТ4/ВІІІ. Анти-ВІЛ 
активність комплексу елаготанінів визначали за знижен-
ням інфекційного титру ВІЛ після зараження вірусом 
клітин МТ-4. Визначали інгібуючий ефект елаготанінів 
на активність ретровірусної зворотної транскриптази, 
РНК-полімерази фага Т7 і Taq-полімерази в безклітин-
них системах Результати. Досліджуваний екстракт 
елаготанінів виявився ефективним інгібітором актив-
ності зворотної транскриптази вірусу мишачої лейкемії, 
РНК-полімерази фага Т7 і Taq-полімерази. Комплекс 
елаготанінів ефективно знижував інфекційний титр ВІЛ 
для клітин МТ-4. IC50 становила 1,5 мкг/мл, а індекс 
селективності дорівнював 87. Висновки. Досліджуваний 
комплекс елаготанінів виявляє виражену анти-ВІЛ ак-
тивність. Противірусний ефект in vitro досягався при 
відносно низькій токсичності. 
К л юч ов і  с л ов а: елаготаніни, ВІЛ, анти-ВІЛ ак-
тивність, зворотна транскриптаза, РНК-полімераза 
фага Т7, Taq-полімераза
Анти-ВИЧ активность эллаготанинов 
из соплодий ольхи 
Т. Ю. Трохимчук, А. С. Шаламай, 
М. П. Завелевич, Л.И. Пальчиковская, 
А. В. Васильченко, С. Л. Рыбалко, Д. Б. Старосила, 
С. Т. Дядюн 
Цель. Изучить ингибирующую активность комплекса 
эллаготаннинов в очищенном экстракте соплодий оль-
хи серой и ольхи клейкой в отношении полимераз, не 
являющихся полимеразами эукариот, и проанализиро-
вать влияние этих веществ на активность обратной 
транскриптазы вируса мышиного лейкоза и на репро-
дукцию ВИЧ in vitro. Методы. Источником ВИЧ слу-
жила хронически инфицированная культура клеток 
лейкоза человека МТ4/ВІІІ. Анти-ВИЧ активность 
комплекса эллаготаннинов определяли по снижению 
инфекционного титра ВИЧ после заражения вирусом 
клеток МТ-4. Определяли ингибирующий эффект 
эллаготаннинов на активность ретровирусной обрат-
ной транскриптазы, РНК-полимеразы фага Т7 и Taq-
полимеразы. Результаты. Исследуемые эллаготанни-
ны оказались эффективными ингибиторами активно-
сти обратной транскриптазы вируса мышиного лейко-
за, РНК-полимеразы фага Т7 и Taq-полимеразы. 
Исследуемый комплекс эллаготаннинов эффективно 
снижал инфекционный титр ВИЧ для клеток МТ-4. 
IC50 составляла 1,5 мкг/мл при индексе селективно-
сти 87. Выводы. Изученный комплекс эллаготаннинов 
обладал выраженной анти-ВИЧ активностью. 
Противовирусный эффект in vitro достигался при от-
носительно низкой токсичности. 
К л юч е в ы е  с л ов а: эллаготаннины, ВИЧ, ан-
ти-ВИЧ активность, обратная транскриптаза, РНК-
полимераза фага Т7, Taq-полимераза 
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